Bildkälla: Stockfoto

Medivir: ESMO Update Supports Next Step for MIV-818 - Redeye

Redeye believes the Phase Ib results support plans for developing combination treatments with MIV-818 in liver cancer.

Redeye believes the Phase Ib results support plans for developing combination treatments with MIV-818 in liver cancer.
Börsvärldens nyhetsbrev
ANNONSER